The primary objective of this clinical practice guideline is to provide gynaecologists with an algorithm and evidence to guide the use of thromboprophylaxis in gynaecological surgery. All patients undergoing gynaecological surgery for benign or malignant indications. The implementation of this guideline ...
Andrade, J. G;
Aguilar, M;
Atzema, C;
Bell, A;
Cairns, J. A;
Cheung, C. C;
Cox, JL;
Dorian, P;
Gladstone, D. J;
Healey, J. S;
Khairy, P;
Leblanc, K;
McMurtry, M. S;
Mitchell, L. B;
Nair, G. M;
Nattel, S;
Parkash, R;
Pilote, L;
Sandhu, R. K;
Sarrazin, J. F;
Sharma, M;
Skanes, A. C;
Talajic, M;
Tsang, T. S. M;
Verma, A;
Verma, S;
Whitlock, R;
Wyse, D. G;
Macle, L.
The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines program was developed to aid clinicians in the management of these complex patients, as well as to provide direction to policy makers and health care systems regarding related issues. The most recent comprehensive CCS AF guidel...
Fibrilación Atrial/diagnóstico,
Fibrilación Atrial/terapia,
Fibrilación Atrial/epidemiología,
Fibrilación Atrial/clasificación,
Factores de Riesgo,
Accidente Cerebrovascular/prevención & control,
Fibrilación Atrial/fisiopatología,
Factores Sexuales,
Grupos de Riesgo,
Algoritmos,
Vías Clínicas
Introducción: Los biomarcadores son útiles en la definición del diagnóstico, pronóstico y seguimiento de múltiples enfermedades. La detección o medición de uno o más biomarcadores específicos representan alteraciones en vías genéticas o epigenéticas que controlan la proliferación, diferenci...
Kokudo, Norihiro;
Takemura, Nobuyuki;
Hasegawa, Kiyoshi;
Takayama, Tadatoshi;
Kubo, Shoji;
Shimada, Mitsuo;
Nagano, Hiroaki;
Hatano, Etsuro;
Izumi, Namiki;
Kaneko, Shuichi;
Kudo, Masatoshi.
The fourth version of Clinical Practice Guidelines for Hepatocellular Carcinoma was revised by the Japan Society of Hepatology, according to the methodology of evidence-based medicine and partly to the Grading of Recommendations Assessment, Development, and Evaluation system, which was published in Octob...
Background
The programmatic management of latent tuberculosis infection (LTBI) in populations most at risk of developing TB remains a critical activity to disrupt Mycobacterium tuberculosis transmission, as identified in the End TB Strategy. LTBI is defined as a state of persistent immune response to sti...
OBJECTIVES: Clinical Practice Guidelines for Pancreatic Cancer based on Evidence-Based Medicine 2006 were first published by the Japan Pancreas Society, and they were revised to Clinical Practice Guidelines for Pancreatic Cancer 2009 in July 2009 and were further revised to Clinical Practice Guidelines f...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the diagnosis of gout. METHODS: This guideline is based on a systematic review of published studies on gout diagnosis, identified using several databases, from da...
Gisbert, JP;
Molina-Infante, J;
Amador, J;
Bermejo, F;
Bujanda, L;
Calvet, X;
Castro-Fernández, M;
Cuadrado-Lavín, A;
Elizalde, JI;
Gene, E;
Gomollón, F;
Lanas, Á;
Martín de Argila, C;
Mearin, F;
Montoro, M;
Pérez-Aisa, Á;
Pérez-Trallero, E;
McNicholl, AG.
Helicobacter pylori approximately infect 50% of Spanish population and causes chronic gastritis, peptic ulcer and gastric cancer. Until now, three consensus meetings on H.pylori infection had been performed in Spain (the last in 2012). The changes in the treatment schemes, and the increasing available ev...
Antibacterianos/uso terapéutico,
Inhibidores de la Bomba de Protones/uso terapéutico,
Bismuto/uso terapéutico,
Algoritmos,
Técnica Delfos,
Quimioterapia Combinada,
Gastritis/complicaciones,
Infecciones por Helicobacter,
Helicobacter pylori,
Probióticos,
Inhibidores de la Bomba de Protones,
Recurrencia,
Terapia Recuperativa,
Neoplasias Gástricas,
Úlcera Gástrica,
Insuficiencia del Tratamiento,
Gastritis/tratamiento farmacológico,
Infecciones por Helicobacter/tratamiento farmacológico,
Helicobacter pylori/efectos de los fármacos
Fernández-Bañares, F;
Accarino, A;
Balboa, A;
Domènech, E;
Esteve, M;
Garcia-Planella, E;
Guardiola, J;
Molero, X;
Rodríguez-Luna, A;
Ruiz-Cerulla, A;
Santos, J;
Vaquero, E.
Chronic diarrhoea is a common presenting symptom in both primary care medicine and in specialized gastroenterology clinics. It is estimated that >5% of the population has chronic diarrhoea and nearly 40% of these patients are older than 60 years. Clinicians often need to select the best diagnostic approa...
Antidiarreicos/uso terapéutico,
Azúcares de la Dieta/efectos adversos,
Algoritmos,
Enfermedad Crónica,
Colitis,
Técnicas de Diagnóstico del Sistema Digestivo,
Diarrea,
Dieta,
Síndromes de Malabsorción/diagnóstico,
Manejo de la Enfermedad,
Insuficiencia Pancreática Exocrina,
Hipersensibilidad a los Alimentos,
Enfermedades Gastrointestinales,
Microbioma Gastrointestinal,
Motilidad Gastrointestinal,
Síndromes de Malabsorción,
Hipersensibilidad a los Alimentos/diagnóstico,
Diarrea/terapia,
Diarrea/diagnóstico,
Diarrea/clasificación
Macle, L;
Cairns, J;
Leblanc, K;
Tsang, T;
Skanes, A;
Cox, JL;
Healey, JS;
Bell, A;
Pilote, L;
Andrade, JG;
Mitchell, LB;
Atzema, C;
Gladstone, D;
Sharma, M;
Verma, S;
Connolly, S;
Dorian, P;
Parkash, R;
Talajic, M;
Nattel, S;
Verma, A.
The Canadian Cardiovascular Society (CCS) Atrial Fibrillation (AF) Guidelines Committee provides periodic reviews of new data to produce focused updates that address clinically important advances in AF management. This 2016 Focused Update deals with: (1) the management of antithrombotic therapy for AF pa...
Anticoagulantes,
Cardiotónicos,
Inhibidores de Agregación Plaquetaria,
Digoxina,
Magnesio,
Síndrome Coronario Agudo/terapia,
Algoritmos,
Anticoagulantes/uso terapéutico,
Apéndice Atrial/cirugía,
Fibrilación Atrial,
Estimulación Cardíaca Artificial,
Cardiotónicos/efectos adversos,
Ablación por Catéter,
Cardiotónicos/administración & dosificación,
Fibrilación Atrial/terapia,
Fibrilación Atrial/complicaciones,
Hemorragia/inducido químicamente,
Hemorragia/prevención & control,
Magnesio/uso terapéutico,
Intervención Coronaria Percutánea,
Inhibidores de Agregación Plaquetaria/uso terapéutico,
Complicaciones Posoperatorias/prevención & control,
Infarto del Miocardio con Elevación del ST/terapia,
Accidente Cerebrovascular/prevención & control,
Enfermedad de la Arteria Coronaria/complicaciones,
Digoxina/administración & dosificación,
Digoxina/efectos adversos,
Quimioterapia Combinada,
Inhibidores del Factor Xa/uso terapéutico,
Fibrinolíticos/uso terapéutico,
Inhibidores del Factor Xa
